3 Stocks That May Be Trading Below Estimated Value By Up To 40.1%

Keefe reiterates Nasdaq stock Outperform rating, $91 target

Mint Incorporation Limited Announces Pricing of $7 million Initial Public Offering and Listing on Nasdaq

Despite the downward trend in earnings at Supernus Pharmaceuticals (NASDAQ:SUPN) the stock advances 3.1%, bringing five-year gains to 56%

NCI Granted Second Grace Period by Nasdaq for Minimum Bid Price Compliance

Wall Street bonuses to climb by 10% or more at biggest banks - report (BAC:NYSE)